CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 40

Industry reads hand-picked by our editors

Sep 19, 2024

Financial Times
Schizophrenia: the new drug set to tackle the ‘cancer of psychiatry’
NPR
Sickle cell gene therapies roll out slowly
C&EN
R&D for long COVID is collapsing

Sep 18, 2024

Bloomberg
Novo Says Ozempic ‘Very Likely’ Target for Next US Price Cut
FirstWord Pharma
Coherus’ Udenyca faces short-term supply squeeze
Endpoints News
After I was diagnosed with Merkel cell carcinoma, I discovered how a band of physician-scientists triggered a revolution

Sep 17, 2024

Axios
Why Trump’s drug price positions may clash with GOP’s pharma agenda
FirstWord Pharma
Roche details external, internal manufacturing plans to support obesity pipeline
The Wall Street Journal
The Battle Brewing Over Blood Tests for Cancer

Sep 16, 2024

MedPage Today
Approved Liver Disease Drug Has No Clinical Benefit, FDA Panel Says
PMLiVE
Eli Lilly announces FDA approval for Ebglyss in moderate-to-severe atopic dermatitis
Financial Times
Eyecare company Bausch + Lomb explores sale to end messy spin-off

Sep 13, 2024

The Wall Street Journal
The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart Monopoly
Science
Insights into notorious ‘Alzheimer’s gene’ fuel hope for staving off dementia
FirstWord Pharma
Neurocrine axes schizophrenia drug luvadaxistat, hones in on two other psychiatric assets

Sep 12, 2024

The Financial Times
How China has ‘throttled’ its private sector
Axios
FDA says Serena Williams drug ad is misleading
STAT
A rare disease program, portrayed as both lifeline and pharma handout, is set to expire
Reuters
Roche shares knocked by concern over side effects in obesity pill trial

Sep 11, 2024

AP News
Saxenda, a weight-loss drug, is effective for kids as young as 6, study shows
Fierce Biotech
Roche ramps up R&D with new high-rise labs
Bloomberg
GTCR Is in Advanced Talks to Buy German Drugmaker Stada
The New York Times
Francisco Lopera, the ‘Country Doctor’ Who Upended Our Understanding of Dementia

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
Structuring Unstructured Data for the Next Generation of Complex Trials Custom content for IMO Health
Trendline
The state of vaccine development in pharma Supported by Thermo Fisher Scientific
Trendline
The latest developments in oncology research Supported by CG Life

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
4 major trends shaping today’s oncology market Webinar - on demand • Provided by Advisory Board

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.